Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction

Journal of Nuclear Cardiology

Volumn 16, Issue 1, 2009, Pages 38-44

  Evangelista, Laura ^a   Acampa, Wanda ^b   Petretta, Mario ^b   Ferro, Adele ^b   Ricci, Francesca ^b   Luongo, Luca ^b   Daniele, Stefania ^b   Punzo, Giorgio ^b   Cuocolo, Alberto ^a,b  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Myocardial viability; Nitrate SPECT; Prognosis

Indexed keywords

ISOSORBIDE DINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; NITRATE; RADIOPHARMACEUTICAL AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMORBIDITY; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; ITALY; METHODOLOGY; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; STATISTICS; SURVIVAL; SURVIVAL RATE;

COMORBIDITY; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITRATES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649644710     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-008-9004-6     Document Type: Article

References (22)

1. Patterson RE, Pilcher WC. Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease. Semin Thorac Cardiovasc Surg 1995;7:214-26.
2. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
3. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
4. Travin MI, Bergmann SR. Assessment of myocardial viability. Semin Nucl Med 2005;35:2-16.
5. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effect of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994;74:843-8.
6. Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
7. Li ST, Liu XJ, Lu ZL, Shi RF, Zhu XD, Chen WQ, et al. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996;3:457-63.
8. Flotats A, Carrió I, Estorch M, Bernà L, Catafau AM, Marí C, et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med 1997;24:767-73.
9. Giorgetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, et al. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: Comparison with baseline Tc-99m tetrofosmin scintigraphy/ FDG PET imaging. J Nucl Cardiol 2004;11:142-51.
10. Acampa W, Evangelista L, Sorrentino AR, Petretta M, Luongo L, Cuocolo A. Single-photon emission computed tomography after nitrate administration predicts cardiac events in patients with previous myocardial infarction and left ventricular dysfunction. J Card Fail 2007;13:765-8.
11. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
12. Arnese M, Cornel JH, Salustri A, Maat A, Elhendy A, Reijs AE, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995;91:2748-52.
13. Imbriaco M, Cuocolo A, Pace L, Nappi A, Nicolai E, Maurea S, et al. Repeatability of haemodynamic responses to cardiac stimulations by ambulatory monitoring of left ventricular function. J Nucl Biol Med 1993;37:238-44.
14. He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, et al. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: Relation to metabolic imaging by PET. J Nucl Cardiol 2003;10:599-606.
15. Maurea S, Cuocolo A, Soricelli A, Castelli L, Nappi A, Squame F, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995;36:1945-52.
16. Diamond GA, Staniloff HM, Forrester JS, Pollok BH, Swan HJC. Computer assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1983;1:444-55.
17. Bax JJ, Van der Wall EE, Haebison M. Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart 2004;90:26-33.
18. Sorrentino AR, Acampa W, Petretta M, Mainolfi C, Salvatore M, Cuocolo A. Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2007;34:558-62.
19. Sciagrà R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-45.
20. Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol 2002;9:454-62.
21. He ZX, Yang MF, Liu XJ, Shi RF, Gao RL, Hu SS, et al. Association of myocardial viability on nitrate-augmented technetium-99m hexakis-2-methoxylisobutyl isonitrile myocardial tomography and intermediate-term outcome in patients with prior myocardial infarction and left ventricular dysfunction. Am J Cardiol 2003;92:696-9.
22. Desideri A, Cortigiani L, Christen AI, Coscarelli S, Gregori D, Zanco P, et al. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 2005;46:1264-9.